These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 23432633)
21. Permeation and skin retention of quercetin from microemulsions containing Transcutol® P. Censi R; Martena V; Hoti E; Malaj L; Di Martino P Drug Dev Ind Pharm; 2012 Sep; 38(9):1128-33. PubMed ID: 22188183 [TBL] [Abstract][Full Text] [Related]
22. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties. Gannu R; Vishnu YV; Kishan V; Rao YM PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343 [TBL] [Abstract][Full Text] [Related]
23. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods. Chen YC; Ho HO; Chiou JD; Sheu MT Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508 [TBL] [Abstract][Full Text] [Related]
24. Supersaturatable formulations for the enhanced oral absorption of sirolimus. Kim MS; Kim JS; Cho W; Cha KH; Park HJ; Park J; Hwang SJ Int J Pharm; 2013 Mar; 445(1-2):108-16. PubMed ID: 23396259 [TBL] [Abstract][Full Text] [Related]
25. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Mehra NK; Verma AK; Mishra PR; Jain NK Biomaterials; 2014 May; 35(15):4573-88. PubMed ID: 24612818 [TBL] [Abstract][Full Text] [Related]
26. The effects of polar excipients transcutol and dexpanthenol on molecular mobility, permeability, and electrical impedance of the skin barrier. Björklund S; Pham QD; Jensen LB; Knudsen NØ; Nielsen LD; Ekelund K; Ruzgas T; Engblom J; Sparr E J Colloid Interface Sci; 2016 Oct; 479():207-220. PubMed ID: 27388135 [TBL] [Abstract][Full Text] [Related]
27. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole. Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772 [TBL] [Abstract][Full Text] [Related]
28. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Chandrasekharan P; Maity D; Yong CX; Chuang KH; Ding J; Feng SS Biomaterials; 2011 Aug; 32(24):5663-72. PubMed ID: 21550654 [TBL] [Abstract][Full Text] [Related]
29. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system. Mu L; Teo MM; Ning HZ; Tan CS; Feng SS J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404 [TBL] [Abstract][Full Text] [Related]
30. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans. Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242 [TBL] [Abstract][Full Text] [Related]
31. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour. Goddeeris C; Van den Mooter G Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442 [TBL] [Abstract][Full Text] [Related]
32. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. Anbharasi V; Cao N; Feng SS J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211 [TBL] [Abstract][Full Text] [Related]
33. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. Youk HJ; Lee E; Choi MK; Lee YJ; Chung JH; Kim SH; Lee CH; Lim SJ J Control Release; 2005 Sep; 107(1):43-52. PubMed ID: 16081183 [TBL] [Abstract][Full Text] [Related]
34. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity. Ishak RA; Osman R Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421 [TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. Baboota S; Al-Azaki A; Kohli K; Ali J; Dixit N; Shakeel F PDA J Pharm Sci Technol; 2007; 61(4):276-85. PubMed ID: 17933209 [TBL] [Abstract][Full Text] [Related]
36. Systems biology approach to study permeability of paracetamol and its solid dispersion. Khan S; Elshaer A; Rahman AS; Hanson P; Perrie Y; Mohammed AR Int J Pharm; 2011 Sep; 417(1-2):272-9. PubMed ID: 21187133 [TBL] [Abstract][Full Text] [Related]
37. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment. Ostacolo C; Caruso C; Tronino D; Troisi S; Laneri S; Pacente L; Del Prete A; Sacchi A Int J Pharm; 2013 Jan; 440(2):148-53. PubMed ID: 23046664 [TBL] [Abstract][Full Text] [Related]
39. Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Han IH; Choi SU; Nam DY; Park YM; Kang MJ; Kang KH; Kim YM; Bae G; Oh IY; Park JH; Ye JS; Choi YB; Kim DK; Lee J; Choi YW Arch Pharm Res; 2010 Feb; 33(2):293-9. PubMed ID: 20195831 [TBL] [Abstract][Full Text] [Related]
40. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. Ke WT; Lin SY; Ho HO; Sheu MT J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]